Prolonged efficiency of secondary prophylaxis with colistin aerosols for respiratory infection due to Pseudomonas aeruginosa in patients infected with human immunodeficiency virus.
Zylberberg
H
H
Service d'Immunologie Clinique, Hôpital Necker, Paris, France.
Vargaftig
J
J
Barbieux
C
C
Pertuiset
N
N
Rothschild
C
C
Viard
J P
JP
D000328:Adult; D000336:Aerosols; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003091:Colistin / Q000008:administration & dosage / Q000627:therapeutic use*; D015658:HIV Infections / Q000150:complications*; D015497:HIV-1; D006801:Humans; D008297:Male; D011552:Pseudomonas Infections / Q000150:complications / Q000188:drug therapy*; D012141:Respiratory Tract Infections / Q000150:complications / Q000188:drug therapy*
D000336:Aerosols; D000900:Anti-Bacterial Agents; D003091:Colistin